J. Yelle

发表

Targeting HIV-1 integrase

K. Sayasith, J. Yelle, G. Sauvé, 2001, Expert opinion on therapeutic targets.

Characterization of Mutant HIV-1 Integrase Carrying Amino Acid Changes in the Catalytic Domain

K. Sayasith, J. Yelle, G. Sauvé, 2000, Molecules and cells.

MERS Coronavirus: Current Status

J. Yelle, 2014 .

The Urgent Need for Broad-Spectrum Antiviral Drugs

J. Yelle, 2015 .

Efficient transfection of mammalian cells with viral DNA in optimal culture conditions.

M. Dion, J. Yelle, C. Hamelin, 1983, Journal of virological methods.

Analysis of recombinant plasmids using multiple agarose slab gels in series

M. Dion, J. Yelle, C. Hamelin, 1984 .

Analysis of long-term viral expression in CEM cells persistently infected with non syncytium-inducing HIV-1 strains

L. Thibodeau, R. Morisset, J. Yelle, 2005, Archives of Virology.

In Vitro Antiviral Activity and Cross-Resistance Proﬁle of PL-100, a Novel Protease Inhibitor of Human Immunodeﬁciency Virus Type 1 (cid:1)

M. Wainberg, J. Schapiro, N. Parkin, 2007 .

Detection of recombination events in human cells using cloned cytomegalovirus DNA fragments as probes.

M. Dion, J. Yelle, C. Hamelin, 1988, Gene analysis techniques.

Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication

C. Lavigne, A. Thierry, J. Yelle, 2001, AAPS PharmSci.

Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?

C. Lavigne, A. Thierry, J. Yelle, 2008, AAPS PharmSci.

A simplified procedure for the rapid identification of recombinant pAT153 plasmids in Escherichia coli HB101 cells.

M. Dion, J. Yelle, C. Hamelin, 1986, Analytical biochemistry.

Direct selection of Escherichiacoli transformed by pAT153 carrying human cytomegalovirus DNA inserts at the Hind III site

M. Dion, J. Yelle, C. Hamelin, 1985 .

Lysine sulfonamides as novel HIV-protease inhibitors: Nε-Acyl aromatic α-amino acids

Jinzi J. Wu, B. Stranix, J. Yelle, 2006 .

1,2,5,6-tetra-O-benzyl-D-mannitol derivatives as novel HIV protease inhibitors.

Abderrahim Bouzide, Gilles Sauvé, Guy Sévigny, 2003, Bioorganic & medicinal chemistry letters.

Unambiguous typing of canine adenovirus isolates by deoxyribonucleic acid restriction-endonuclease analysis.

G. Marsolais, J. Yelle, C. Hamelin, 1983, Canadian journal of comparative medicine : Revue canadienne de medecine comparee.

Expression of virus-like particles in normal and transformed gerbil cells

J. Yelle, L. Berthiaume, 2005, Archives of Virology.

Lysine sulfonamides as novel HIV-protease inhibitors: Nε-disubstituted ureas

A. Côté, B. Stranix, J. Yelle, 2004 .

Fast electrophoresis in superposed agarose minigels for DNA topoisomerase assays

M. Dion, J. Yelle, C. Hamelin, 1986 .

Increased DNA topoisomerase I activity in aging human cell chromatin

M. Dion, J. Yelle, C. Hamelin, 1984, Bioscience reports.

Distinct regions of the human cytomegalovirus genome are responsible for the immortalization and tumorigenicity of animal cells.

M. Dion, J. Yelle, C. Hamelin, 1986, Cancer letters.

Transformation of dog embryo kidney cells by human herpesviruses.

J. Yelle, C. Hamelin, 1986, Cell biology international reports.

The 2014 Ebola Virus Outbreak in West Africa: Current Perspectives for Prevention and Treatment

J. Yelle, 2014 .

Antiviral activity and cross-resistance profile of P-1946, a novel human immunodeficiency virus type 1 protease inhibitor.

C. Petropoulos, B. Conway, Y. Lie, 2006, Antiviral research.

Efficient recovery of cloned human cytomegalovirus DNA fragments from agarose gels.

A. Pramatarova, J. Yelle, C. Hamelin, 1994, Journal of Virological Methods.

A biotin-conjugated substrate facilitating analysis of HIV-1 integrase activity on minigels.

K. Sayasith, J. Yelle, G. Sauvé, 2000, Analytical biochemistry.

In Vitro Antiviral Activity and Cross-Resistance Profile of PL-100, a Novel Protease Inhibitor of Human Immunodeficiency Virus Type 1

M. Wainberg, J. Schapiro, N. Parkin, 2007, Antimicrobial Agents and Chemotherapy.

Lysine sulfonamides as novel HIV-Protease inhibitors: optimization of the Nε-acyl-phenyl spacer

A. Côté, B. Stranix, J. Yelle, 2003 .

Lysine sulfonamides as novel HIV-protease inhibitors: optimization of the Nepsilon-acyl-phenyl spacer.

A. Côté, B. Stranix, J. Yelle, 2003, Bioorganic & medicinal chemistry letters.

The Challenges of Poliovirus Eradication

J. Yelle, 2016 .

Lysine derivatives as potent HIV protease inhibitors. Discovery, synthesis and structure-activity relationship studies.

J. Yelle, G. Sauvé, A. Bouzide, 2005, Bioorganic & medicinal chemistry letters.